Breast Tumor Specimen Data Table

1 TUMOR ID NEW YORK 3 STANFORD 14 NORWAY 41 STANFORD 23 NEW YORK 2 NORWAY 109 NORWAY 53 STANFORD 2 NORWAY 57 NORWAY 47 NORWAY 101 STANFORD 37-FA NORWAY 61 NORWAY 65 NORWAY 112 NORWAY 14 STANFORD 17 NORWAY 48 NORWAY 15 NORWAY 7 NORWAY 26 NORWAY 19 NORWAY 11 NORWAY 104 NORWAY 12 NORWAY 100 NORWAY 39 NORWAY 17 NORWAY 10 NORWAY 102 NEW YORK 1 STANFORD 35 STANFORD 38 STANFORD 16 NORWAY 111 STANFORD 24 NORWAY 27 NORWAY 18 NORWAY 16 NORWAY 56
2 ER Clinical negative negative positive negative negative negative positive negative negative positive positive not tested positive negative positive positive positive negative positive positive positive positive positive positive positive positive positive positive positive positive not tested positive positive positive positive positive positive positive positive positive
3 ESR1 Array 0.42 1.25 1.1 0.83 1 0.44 0.93 1 0.88 2.28 0.47 2.25 2.27 8.6 3.35 0.71 9.1 0.81 5.48 6 9.1 7.9 8.65 10.8 31.88 19 12 32.9 4.6 12.3 16 10.93 14.5 21.6 18.9 16.99 29 27.81 18.9 33

4 Erb-B2 Clinical not tested not tested negative negative not tested negative positive positive positive not tested positive not tested positive negative negative negative not tested negative negative negative positive negative positive positive positive negative negative negative negative negative not tested positive positive not tested negative negative negative negative negative negative
5 Erb-B2 Array 3.4 6.1 2.97 1.48 1.7 1.35 21.5 22.6 15.5 9.5 23.3 4.44 12.1 1.52 1.75 8.15 4.6 2.7 1.57 1.9 10.8 1.43 3.3 3.15 3.9 1.45 1.46 2.5 2.2 2.2 2.4 2.47 5.76 1.68 0.87 1.88 2.8 2.32 3.96 1.49

6 Tumor Grade 3 2 3 3 3 3 3 3 3   3   2 3 3 2 2 3 3 2 2 3 3 3 3 3 2 2 2 3 2 3 2 3 3 2 1 2 3 3
7 Differentiation ductal ductal ductal ductal ductal ductal ductal ductal ductal DCIS ductal fibroadenoma lobular ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal lobular ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal ductal

8 Special Notes
 
1= tumor name as it appears in the figures
2= clinical estrogen receptor status (determined by dextran binding assay and/or immunohistochemistry)
3= average R/G ratio of two independent sequence verified ESR1 clones (the correlation between clinical ER status and the microarray data is best if one calls a R/G ratio of 2.25 or greater "positive" for ER)
4= Erb-B2 clinical status as determined by immunohistochemistry
5= average R/G ratio of four independent sequence verified Erb-B2 clones (the correlation between clinical Erb-B2 status and the microarray data is best if one calls a microarray ratio of 3.15 or greater "positive" for Erb-B2)
6= tumor grade
7= differentiation status
8= additional findings and comments

Last Updated on 05/04/2000
By Charles M. Perou
Email: perou@genome.stanford.edu